Preparation of AgBr@SiO2 core@shell hybrid nanoparticles and their bactericidal activity.
Identifieur interne : 000919 ( Main/Corpus ); précédent : 000918; suivant : 000920Preparation of AgBr@SiO2 core@shell hybrid nanoparticles and their bactericidal activity.
Auteurs : Yuanyuan Li ; Lisu Yang ; Yanbao Zhao ; Binjie Li ; Lei Sun ; Huajuan LuoSource :
- Materials science & engineering. C, Materials for biological applications [ 1873-0191 ] ; 2013.
English descriptors
- KwdEn :
- Anti-Bacterial Agents (chemical synthesis), Anti-Bacterial Agents (pharmacology), Bromides (chemical synthesis), Bromides (pharmacology), Escherichia coli (drug effects), Escherichia coli (growth & development), Microbial Sensitivity Tests (MeSH), Nanoparticles (chemistry), Nanoparticles (ultrastructure), Pseudomonas aeruginosa (drug effects), Pseudomonas aeruginosa (growth & development), Silicon Dioxide (chemical synthesis), Silicon Dioxide (pharmacology), Silver Compounds (chemical synthesis), Silver Compounds (pharmacology), Staphylococcus aureus (drug effects), Staphylococcus aureus (growth & development), X-Ray Diffraction (MeSH).
- MESH :
- chemical , chemical synthesis : Anti-Bacterial Agents, Bromides, Silicon Dioxide, Silver Compounds.
- chemical , pharmacology : Anti-Bacterial Agents, Bromides, Silicon Dioxide, Silver Compounds.
- chemistry : Nanoparticles.
- drug effects : Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus.
- growth & development : Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus.
- ultrastructure : Nanoparticles.
- Microbial Sensitivity Tests, X-Ray Diffraction.
Abstract
AgBr@SiO2 core@shell hybrid nanoparticles (NPs) were successfully prepared by sol-gel method. Their morphology and structure were characterized by transmission electron microscopy (TEM) and X-ray diffraction (XRD). The hybrid NPs are predominantly spherical in shape, with an average diameter of 180-200 nm, and each NP contains one inorganic core. The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of the hybrid NPs were examined against Staphylococcus aureus (S. aureus), Pseudomonas aeruginosa (P. aeruginosa) and Escherichia coli (E. coli), respectively. Results indicated that the AgBr@SiO2 NPs had excellent antibacterial activity.
DOI: 10.1016/j.msec.2012.12.016
PubMed: 23827640
Links to Exploration step
pubmed:23827640Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Preparation of AgBr@SiO2 core@shell hybrid nanoparticles and their bactericidal activity.</title><author><name sortKey="Li, Yuanyuan" sort="Li, Yuanyuan" uniqKey="Li Y" first="Yuanyuan" last="Li">Yuanyuan Li</name><affiliation><nlm:affiliation>Key Laboratory for Special Functional Materials of Ministry of Education, Henan University, Kaifeng 475004, China.</nlm:affiliation></affiliation></author><author><name sortKey="Yang, Lisu" sort="Yang, Lisu" uniqKey="Yang L" first="Lisu" last="Yang">Lisu Yang</name></author><author><name sortKey="Zhao, Yanbao" sort="Zhao, Yanbao" uniqKey="Zhao Y" first="Yanbao" last="Zhao">Yanbao Zhao</name></author><author><name sortKey="Li, Binjie" sort="Li, Binjie" uniqKey="Li B" first="Binjie" last="Li">Binjie Li</name></author><author><name sortKey="Sun, Lei" sort="Sun, Lei" uniqKey="Sun L" first="Lei" last="Sun">Lei Sun</name></author><author><name sortKey="Luo, Huajuan" sort="Luo, Huajuan" uniqKey="Luo H" first="Huajuan" last="Luo">Huajuan Luo</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="RBID">pubmed:23827640</idno><idno type="pmid">23827640</idno><idno type="doi">10.1016/j.msec.2012.12.016</idno><idno type="wicri:Area/Main/Corpus">000919</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000919</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Preparation of AgBr@SiO2 core@shell hybrid nanoparticles and their bactericidal activity.</title><author><name sortKey="Li, Yuanyuan" sort="Li, Yuanyuan" uniqKey="Li Y" first="Yuanyuan" last="Li">Yuanyuan Li</name><affiliation><nlm:affiliation>Key Laboratory for Special Functional Materials of Ministry of Education, Henan University, Kaifeng 475004, China.</nlm:affiliation></affiliation></author><author><name sortKey="Yang, Lisu" sort="Yang, Lisu" uniqKey="Yang L" first="Lisu" last="Yang">Lisu Yang</name></author><author><name sortKey="Zhao, Yanbao" sort="Zhao, Yanbao" uniqKey="Zhao Y" first="Yanbao" last="Zhao">Yanbao Zhao</name></author><author><name sortKey="Li, Binjie" sort="Li, Binjie" uniqKey="Li B" first="Binjie" last="Li">Binjie Li</name></author><author><name sortKey="Sun, Lei" sort="Sun, Lei" uniqKey="Sun L" first="Lei" last="Sun">Lei Sun</name></author><author><name sortKey="Luo, Huajuan" sort="Luo, Huajuan" uniqKey="Luo H" first="Huajuan" last="Luo">Huajuan Luo</name></author></analytic><series><title level="j">Materials science & engineering. C, Materials for biological applications</title><idno type="eISSN">1873-0191</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anti-Bacterial Agents (chemical synthesis)</term><term>Anti-Bacterial Agents (pharmacology)</term><term>Bromides (chemical synthesis)</term><term>Bromides (pharmacology)</term><term>Escherichia coli (drug effects)</term><term>Escherichia coli (growth & development)</term><term>Microbial Sensitivity Tests (MeSH)</term><term>Nanoparticles (chemistry)</term><term>Nanoparticles (ultrastructure)</term><term>Pseudomonas aeruginosa (drug effects)</term><term>Pseudomonas aeruginosa (growth & development)</term><term>Silicon Dioxide (chemical synthesis)</term><term>Silicon Dioxide (pharmacology)</term><term>Silver Compounds (chemical synthesis)</term><term>Silver Compounds (pharmacology)</term><term>Staphylococcus aureus (drug effects)</term><term>Staphylococcus aureus (growth & development)</term><term>X-Ray Diffraction (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="chemical synthesis" xml:lang="en"><term>Anti-Bacterial Agents</term><term>Bromides</term><term>Silicon Dioxide</term><term>Silver Compounds</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Anti-Bacterial Agents</term><term>Bromides</term><term>Silicon Dioxide</term><term>Silver Compounds</term></keywords><keywords scheme="MESH" qualifier="chemistry" xml:lang="en"><term>Nanoparticles</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Escherichia coli</term><term>Pseudomonas aeruginosa</term><term>Staphylococcus aureus</term></keywords><keywords scheme="MESH" qualifier="growth & development" xml:lang="en"><term>Escherichia coli</term><term>Pseudomonas aeruginosa</term><term>Staphylococcus aureus</term></keywords><keywords scheme="MESH" qualifier="ultrastructure" xml:lang="en"><term>Nanoparticles</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Microbial Sensitivity Tests</term><term>X-Ray Diffraction</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">AgBr@SiO2 core@shell hybrid nanoparticles (NPs) were successfully prepared by sol-gel method. Their morphology and structure were characterized by transmission electron microscopy (TEM) and X-ray diffraction (XRD). The hybrid NPs are predominantly spherical in shape, with an average diameter of 180-200 nm, and each NP contains one inorganic core. The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of the hybrid NPs were examined against Staphylococcus aureus (S. aureus), Pseudomonas aeruginosa (P. aeruginosa) and Escherichia coli (E. coli), respectively. Results indicated that the AgBr@SiO2 NPs had excellent antibacterial activity.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23827640</PMID><DateCompleted><Year>2014</Year><Month>01</Month><Day>30</Day></DateCompleted><DateRevised><Year>2013</Year><Month>07</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-0191</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>3</Issue><PubDate><Year>2013</Year><Month>Apr</Month><Day>01</Day></PubDate></JournalIssue><Title>Materials science & engineering. C, Materials for biological applications</Title><ISOAbbreviation>Mater Sci Eng C Mater Biol Appl</ISOAbbreviation></Journal><ArticleTitle>Preparation of AgBr@SiO2 core@shell hybrid nanoparticles and their bactericidal activity.</ArticleTitle><Pagination><MedlinePgn>1808-12</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.msec.2012.12.016</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0928-4931(12)00573-5</ELocationID><Abstract><AbstractText>AgBr@SiO2 core@shell hybrid nanoparticles (NPs) were successfully prepared by sol-gel method. Their morphology and structure were characterized by transmission electron microscopy (TEM) and X-ray diffraction (XRD). The hybrid NPs are predominantly spherical in shape, with an average diameter of 180-200 nm, and each NP contains one inorganic core. The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of the hybrid NPs were examined against Staphylococcus aureus (S. aureus), Pseudomonas aeruginosa (P. aeruginosa) and Escherichia coli (E. coli), respectively. Results indicated that the AgBr@SiO2 NPs had excellent antibacterial activity.</AbstractText><CopyrightInformation>Copyright © 2012 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yuanyuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Key Laboratory for Special Functional Materials of Ministry of Education, Henan University, Kaifeng 475004, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Lisu</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Yanbao</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Binjie</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Lei</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Huajuan</ForeName><Initials>H</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>12</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Mater Sci Eng C Mater Biol Appl</MedlineTA><NlmUniqueID>101484109</NlmUniqueID><ISSNLinking>0928-4931</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001965">Bromides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018030">Silver Compounds</NameOfSubstance></Chemical><Chemical><RegistryNumber>7631-86-9</RegistryNumber><NameOfSubstance UI="D012822">Silicon Dioxide</NameOfSubstance></Chemical><Chemical><RegistryNumber>NHQ37BJZ2Z</RegistryNumber><NameOfSubstance UI="C047751">silver bromide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000138" MajorTopicYN="Y">chemical synthesis</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001965" MajorTopicYN="N">Bromides</DescriptorName><QualifierName UI="Q000138" MajorTopicYN="Y">chemical synthesis</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004926" MajorTopicYN="N">Escherichia coli</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000254" MajorTopicYN="N">growth & development</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008826" MajorTopicYN="N">Microbial Sensitivity Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053758" MajorTopicYN="N">Nanoparticles</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011550" MajorTopicYN="N">Pseudomonas aeruginosa</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000254" MajorTopicYN="N">growth & development</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012822" MajorTopicYN="N">Silicon Dioxide</DescriptorName><QualifierName UI="Q000138" MajorTopicYN="Y">chemical synthesis</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018030" MajorTopicYN="N">Silver Compounds</DescriptorName><QualifierName UI="Q000138" MajorTopicYN="Y">chemical synthesis</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013211" MajorTopicYN="N">Staphylococcus aureus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000254" MajorTopicYN="N">growth & development</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014961" MajorTopicYN="N">X-Ray Diffraction</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AgBr@SiO(2)</Keyword><Keyword MajorTopicYN="N">Antibacterial activity</Keyword><Keyword MajorTopicYN="N">Chemical synthesis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>07</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2012</Year><Month>09</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>12</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>7</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>7</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23827640</ArticleId><ArticleId IdType="pii">S0928-4931(12)00573-5</ArticleId><ArticleId IdType="doi">10.1016/j.msec.2012.12.016</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Terre/explor/SilverBacteriV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000919 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000919 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Terre
|area= SilverBacteriV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= pubmed:23827640
|texte= Preparation of AgBr@SiO2 core@shell hybrid nanoparticles and their bactericidal activity.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:23827640" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a SilverBacteriV1
| This area was generated with Dilib version V0.6.38. |  |